I now have all the material needed for a comprehensive answer. Here is the full structured review:
Chronic Suppurative Otitis Media (CSOM)
Definition
CSOM is defined as a persistent, chronic infection of the middle ear and mastoid associated with a non-intact tympanic membrane (TM) and chronic otorrhoea lasting more than 6-12 weeks. It is broadly divided into two clinically distinct types based on the site of TM pathology and risk of serious complications.
Classification
| Feature | Tubotympanic (Safe) | Atticoantral (Unsafe) |
|---|
| TM perforation | Central (pars tensa) | Marginal / attic (pars flaccida) |
| Cholesteatoma | Absent | Present (common) |
| Discharge | Mucoid, non-offensive | Scanty, foul-smelling |
| Bone erosion | Rare | Frequent |
| Complications | Less common | Common, serious |
- The tubotympanic type shows retraction of the TM confined to the pars tensa
- The atticoantral type involves pars flaccida retraction and cholesteatoma is commonly present
(KJ Lee's Essential Otolaryngology, p.446)
Epidemiology & Risk Factors
- Most common in low socioeconomic settings with limited healthcare access
- Peak age: children under 2 years old
- Risk factors include:
- Multiple prior episodes of acute otitis media (AOM)
- AOM in the first months of life
- Chronic secretory otitis media
- Eustachian tube (ET) dysfunction
- Genetic predisposition (higher incidence in Inuit, Native Americans, Aboriginal Australians/New Zealanders)
- Nasopharyngeal reflux
(KJ Lee's Essential Otolaryngology, p.445)
Pathophysiology
The central mechanism is Eustachian tube dysfunction leading to negative middle ear pressure. This process unfolds in stages:
- ET dysfunction → decreased middle ear aeration → nitrogen absorption by mastoid cells → negative middle ear pressure
- Negative pressure → TM retraction (pars flaccida most susceptible) → effusion (serous or purulent) → mucosal oedema
- Bacterial infection → purulent effusion → inflammatory mediators → chronic mucosal changes, submucosal gland metaplasia (secretory mucosa perpetuates effusion)
- Granulation tissue forms as bacterial toxins disrupt the basement membrane; inflammatory cells extrude, fibroblasts and angiogenic factors are recruited → polyp formation
- TM weakening - enzymes in granulation tissue and effusion break down the collagen skeleton of the TM; combined with negative pressure → retraction pockets deepen → contact with underlying mucosa → perforation
- Cholesteatoma genesis - deep retraction pockets and perforations allow keratinizing squamous epithelium to invade the middle ear, leading to cholesteatoma
Biofilm plays a critical role: Pseudomonas aeruginosa and other organisms form highly organized, sessile bacterial networks embedded in an oligopolysaccharide matrix that resists phagocytosis, humoral immunity, and antibiotics (including efflux pump upregulation).
(Shambaugh Surgery of the Ear, p.527; KJ Lee's Essential Otolaryngology, p.445-446)
Microbiology
Aerobic bacteria dominate, with the following distribution from a study of 146 patients:
| Organism | % of cultures |
|---|
| Pseudomonas aeruginosa | 31.1% |
| Staphylococcus aureus | 19.1% |
| Proteus mirabilis | 7.7% |
| Escherichia coli | 1.4% |
| Klebsiella pneumoniae | 1.0% |
| Peptococcus (anaerobe) | 12.4% |
| Bacteroides sp. (anaerobe) | 12.4% |
| Peptostreptococcus (anaerobe) | 4.8% |
Also: non-typeable H. influenzae, M. catarrhalis, and anaerobes (Fusobacterium, Clostridium). Malodorous discharge typically signals anaerobic involvement. Fungal overgrowth (Candida spp.) occurs in up to 35% of ears treated with prolonged topical fluoroquinolones.
(Cummings Otolaryngology, p. Table 140.1; KJ Lee's Essential Otolaryngology, p.446)
Clinical Features
History:
- Intermittent or continuous otorrhoea (sometimes foul-smelling with anaerobes)
- Conductive hearing loss (the most common functional deficit)
- Otalgia and headache are uncommon - their presence should raise suspicion for intracranial involvement or malignancy
- Vertigo should raise suspicion for labyrinthitis or labyrinthine fistula
Examination:
- Otoscopy/otomicroscopy: TM perforation, retraction pockets, atelectasis; otorrhoea may obscure the TM
- Inspect for: scutal erosion, ossicular erosion, granulation tissue, aural polyps
- An aural polyp should be considered cholesteatoma until proven otherwise
- White keratin debris in the attic region = cholesteatoma (primary acquired type - see below)
(Shambaugh Surgery of the Ear, p.527-528)
Otoscopic Images
Otoscopic view showing a large central perforation with mucoid discharge and tympanosclerotic plaques - typical of tubotympanic CSOM
Primary acquired attic cholesteatoma with pars flaccida defect and keratin debris - the hallmark of atticoantral (unsafe) CSOM (Cummings Otolaryngology, Fig. 140.5)
Cholesteatoma
Aural cholesteatomas are epidermal inclusions of the middle ear or mastoid containing desquamated keratin debris within a keratinizing squamous epithelial lining. They may be:
- Congenital (rare, present behind intact TM in young children)
- Primary acquired - keratinizing epithelium migrates through a pars flaccida retraction pocket
- Secondary acquired - epithelium migrates through a pre-existing TM perforation
Their clinical importance lies in their aggressive bone-erosive behaviour driven by enzymatic destruction and pressure necrosis.
Diagnosis
- Otomicroscopy with pneumatic insufflation - identifies retraction pockets, mobility, cholesteatoma
- Audiometry - conductive hearing loss is typical (low frequency); mixed hearing loss if sensorineural damage has occurred. A conductive loss >30 dB suggests ossicular erosion
- High-resolution CT temporal bones - indicated for surgical planning, complicated CSOM, and identified or suspected cholesteatoma
- MRI with contrast - for suspected intracranial complications
- Biopsy of granulation tissue unresponsive to topical therapy - to exclude malignancy (squamous carcinoma of temporal bone is associated with long-standing CSOM)
- Ear swab for culture - guides antibiotic selection
(KJ Lee's Essential Otolaryngology, p.446)
Management
Primary Goal
Create a safe, dry ear: dry = no otorrhoea; safe = no keratin accumulation, minimal risk of suppurative complications.
Medical Treatment
1. Aural toilet - regular microsuction/dry mopping to debride discharge and remove debris; this alone can achieve drying and is a prerequisite to topical therapy
2. Topical antibiotics (first-line):
- Ciprofloxacin ear drops - the most evidence-supported agent; fluoroquinolones are preferred because they are non-ototoxic and active against Pseudomonas
- A 4-6 week course following debridement
- 2025 Cochrane evidence: Three Cochrane meta-analyses published June 2025 confirm topical antibiotics are more effective than systemic antibiotics or topical antiseptics for CSOM. Topical antiseptics (acetic acid, Burow's solution) remain an alternative.
- Biofilms are frequently resistant; high concentrations from topical delivery partially overcome this
3. Systemic antibiotics - a role in CSOM with systemic signs or where topical therapy fails; recent
Cochrane review (2025) found systemic antibiotics are inferior to topical for most cases; reserved for acute exacerbations or perichondritis
4. Topical antiseptics - acetic acid (2%), povidone-iodine; inferior to fluoroquinolones per 2025
Cochrane comparison
Indications for Surgery
- Cholesteatoma combined with medically refractory CSOM = near-absolute indication
- Failure of multiple courses of medical treatment
- Symptoms suspicious of complications: vertigo, facial weakness, headache
- Deep retraction pockets threatening ossicular chain
- Persistent conductive hearing loss
Surgical Options
The three surgical priorities are: (1) eradication of disease, (2) prevention of recurrence, (3) preservation or restoration of hearing.
| Procedure | Description | Indication |
|---|
| Myringoplasty | TM repair alone (patch graft) | Simple perforation, no middle ear/mastoid disease |
| Tympanoplasty | TM repair ± ossicular chain reconstruction | Perforation with ossicular involvement |
| Canal wall-up (CWU) mastoidectomy | Mastoid exenteration preserving posterior EAC wall | Limited cholesteatoma; patient preference for normal anatomy |
| Canal wall-down (CWD) mastoidectomy | Posterior EAC wall removed; open cavity created | Extensive cholesteatoma; revision surgery; unresectable matrix |
CWU vs CWD trade-offs:
- CWD provides better surgical access and potentially lower recurrence, but results in an open cavity requiring lifelong routine follow-up and debridement
- CWU preserves normal anatomy and dramatically reduces post-op convalescence, but higher disease recurrence risk for cholesteatoma
- Anatomical position of cholesteatoma is a stronger predictor of recurrence than choice of technique
(Shambaugh Surgery of the Ear, p.529)
Complications
Complications arise from direct bony erosion (by cholesteatoma enzymes or granulation tissue) or spread of infection through destroyed barriers.
Intracranial Complications
- Meningitis
- Brain abscess (temporal lobe, cerebellar)
- Epidural/subdural abscess
- Sigmoid sinus thrombophlebitis
- Otitic hydrocephalus
Extracranial Complications
- Labyrinthine fistula (most commonly horizontal semicircular canal) - presents with vertigo and SNHL
- Facial nerve paralysis - acute (infection) or insidious (cholesteatoma expansion through fallopian canal)
- Coalescent mastoiditis / subperiosteal abscess
- Petrositis (Gradenigo syndrome: otorrhoea, ipsilateral abducens palsy, deep facial pain)
- Ossicular erosion (most commonly the long process of the incus) → conductive hearing loss
- Tegmen tympani/mastoideum erosion → CSF leak, brain herniation
(Cummings Otolaryngology, Box 140.1)
Key Points Summary
- CSOM = TM perforation + chronic otorrhoea >6 weeks; tubotympanic (safe) vs atticoantral (unsafe/cholesteatoma)
- Core pathophysiology: ET dysfunction → negative middle ear pressure → TM retraction → perforation/cholesteatoma
- Most common pathogen: Pseudomonas aeruginosa; mixed aerobic/anaerobic flora
- Foul-smelling discharge = anaerobes/cholesteatoma; malodour is a red flag for the atticoantral type
- An aural polyp = cholesteatoma until proven otherwise
- Otalgia/headache/vertigo/facial weakness = possible complications; urgent evaluation needed
- Topical ciprofloxacin + aural toilet is first-line medical treatment (2025 Cochrane evidence confirms superiority over systemic antibiotics)
- Surgery (tympanoplasty ± mastoidectomy) is indicated for cholesteatoma, treatment failure, or complications
- Cholesteatoma is aggressive: erodes ossicles, otic capsule, fallopian canal, tegmen - treat surgically without delay
- Long-term surveillance is mandatory after CWD mastoidectomy
Sources: Shambaugh Surgery of the Ear, pp.527-529 | Cummings Otolaryngology Head & Neck Surgery, Table 140.1, Box 140.1 | KJ Lee's Essential Otolaryngology, pp.445-446 | Cochrane Database Syst Rev 2025 (PMIDs:
40484407,
40484405,
40484400)